Skip to main content

Retail Clinics

  • Sunbow officially unveils kid-friendly sun care products

    NEW YORK — Sunbow officially unveiled at a press event in New York on Wednesday its new line of sun care products specially designed for children.

    The new product line is comprised of seven SKUs formulated with micronized zinc oxide formulas to provide a strong UVA/UVB barrier without the chemical actives, such as oxybenzone or octinoxate.

  • Bayer Advanced Aspirin officially launches

    MORRISTOWN, N.J. — Bayer on Tuesday introduced its new Bayer Advanced Aspirin, billed as relieving pain “twice as fast” as the previous Extra Strength Bayer Aspirin.

    Using a patent-pending Pro-Release technology, the particles in the new formulation are one-tenth the size of Extra Strength Bayer Aspirin and dissolve six times faster.

  • XRP Energy gears up for nationwide launch

    HATTIESBURG, Miss. — Top Five Labs on Monday announced its intent to expand distribution of its XRP Energy product — endorsed by former National Football League quarterback Brett Favre — nationwide after a successful test launch in select convenience stores and marts throughout Alabama, Mississippi, Florida, Wisconsin and Minnesota.

  • Lilly for Better Health provides patients with ways to improve well-being

    INDIANAPOLIS — Drug maker Eli Lilly has created a multichannel platform to inform and educate patients about healthy eating, physical activity and stress management.

    The program, Lilly for Better Health, is designed to help users live healthier, more active lives, and Lilly said it was designed to reach patients where they like to receive health information. The program includes a website, LillyForBetterHealth.com.

  • Cypress gets OK for cough-cold medications Zutripro, Rezira

    MADISON, Miss. — The Food and Drug Administration has approved two cough-cold medications made by Cypress Pharmaceutical, the company said Monday.

    Cypress announced the approval of Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine hydrochloride) and Rezira (hydrocodone bitartrate and pseudoephedrine). Both drugs are oral solutions and, because they contain the opioid hydrocodone, are classified as schedule III controlled substances by the Drug Enforcement Administration. Cypress subsidiary Hawthorn Pharmaceuticals will market the drugs.

  • Study finds possible link between ADT, diabetes

    BOSTON — Men with prostate cancer are at a higher risk of developing diabetes or diabetes risk factors if they receive a therapy designed to block the production of testosterone, a new study has suggested.

  • MinuteClinic, OhioHealth enter strategic clinical affiliation

    WOONSOCKET, R.I., and COLUMBUS, Ohio — MinuteClinic has entered a clinical affiliation with OhioHealth, a not-for-profit, charitable healthcare organization based in Columbus. MinuteClinic has seven walk-in medical clinics inside select CVS/pharmacy stores throughout the region.

  • Health 2.0, Walgreens announce health guide challenge

    SAN FRANCISCO — Health 2.0 and Walgreens on Thursday announced the launch of the Walgreens 2011 Challenge: A New Approach to Patient Information Navigation, which invites teams of developers to create an application that presents aggregated U.S. Department of Health and Human Services data on specific health topics.

    The challenge is being sponsored by Walgreens, as part of the Health 2.0 Developer Challenge, as a way to supply both Walgreens healthcare staff and patients with a tool for searching and learning about health-related topics, the companies stated.

X
This ad will auto-close in 10 seconds